The present invention is directed to novel thia-tetraazaacenaphthylene compounds of Formula (I):
and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of ATP-protein kinase interactions.
The present invention is directed to thienopyrimidine compounds of formula (I):
and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
[EN] THIA-TETRAAZAACENAPHTHYLENE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE LA THIA-TETRAAZAACENAPHTYLENE KINASE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2006118749A1
公开(公告)日:2006-11-09
[EN] The present invention is directed to novel thia-tetraazaacenaphthylene compounds of Formula (I): and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of ATP-protein kinase interactions. [FR] La présente invention porte sur de nouveaux composés du thia-tétraazaacénaphtylène de formule (I) et des formes pharmaceutiquement acceptables de ceux-ci, ainsi que sur leur synthèse et leur utilisation en tant qu'inhibiteurs des interactions avec l'ATP protéine kinase.